Phaxiam Therapeutics S.a. sell Lokrim
Start price
11.11.24
/
20%
€1.69
Target price
11.11.25
-
Performance (%)
-94.96%
End price
29.09.25
-
Summary
This prediction is currently being closed. Massive losses of -94.96% have been the result for the SELL prediction by Lokrim. Lokrim has 20% into this predictionPerformance without dividends (%)
| Name | 1w | 1m | 1y |
|---|---|---|---|
| Phaxiam Therapeutics S.a. | - | - | - |
| iShares Core DAX® | 0.734% | -0.964% | 17.910% |
| iShares Nasdaq 100 | -2.686% | -2.409% | 4.267% |
| iShares Nikkei 225® | -2.261% | -4.038% | 10.420% |
| iShares S&P 500 | -1.346% | -1.510% | 1.615% |
According to Lokrim what are the pros and cons of Phaxiam Therapeutics S.a. for the foreseeable future?
Pros
Cons
Significant cyclical dependencies
ROE lower than 10% per year
Comments by Lokrim for this prediction
In the thread Phaxiam Therapeutics S.a. diskutieren
Sell Phaxiam Therapeutics S.a.
In the thread Trading Phaxiam Therapeutics S.a.
Stopped prediction by Lokrim for Phaxiam Therapeutics S.a.
Phaxiam Therapeutics S.a.
Start price
Target price
Perf. (%)
€2.80
04.03.24
04.03.24
-
04.03.25
04.03.25
-38.57%
17.08.24
17.08.24
Significant cyclical dependencies
